These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29676873)

  • 21. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials.
    Bertrand ME
    Curr Med Res Opin; 2004 Oct; 20(10):1559-69. PubMed ID: 15462689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trials.
    Brady AJ
    Clin Drug Investig; 2007; 27(3):149-61. PubMed ID: 17305412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelium-dependent effects of converting-enzyme inhibitors.
    Vanhoutte PM; Boulanger CM; Illiano SC; Nagao T; Vidal M; Mombouli JV
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S10-6. PubMed ID: 7508046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment.
    Buda V; Andor M; Petrescu L; Cristescu C; Baibata DE; Voicu M; Munteanu M; Citu I; Muntean C; Cretu O; Tomescu MC
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28178210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes].
    Inzhutova AI; Salmina AB; Petrova MM
    Kardiologiia; 2007; 47(8):49-52. PubMed ID: 18260912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice.
    Akishita M; Shirakami G; Iwai M; Wu L; Aoki M; Zhang L; Toba K; Horiuchi M
    J Hypertens; 2001 Jun; 19(6):1083-8. PubMed ID: 11403357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
    Tom B; Dendorfer A; Danser AH
    Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endothelial mechanisms in vasomotor effects of ACE inhibitors].
    Busse R; Hecker M
    Z Kardiol; 1994; 83 Suppl 4():1-6. PubMed ID: 7856274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perindopril for the treatment of hypertension.
    Ghiadoni L
    Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
    Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
    Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril.
    Ancion A; Tridetti J; Nguyen Trung ML; Oury C; Lancellotti P
    Cardiol Ther; 2019 Dec; 8(2):179-191. PubMed ID: 31578675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine.
    Borghi C; Morbini M; Cicero AF
    J Cardiovasc Med (Hagerstown); 2015 May; 16(5):390-9. PubMed ID: 25590639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the endothelial mechanisms of ACE-Is already established?
    Buczko W; Kramkowski K; Mogielnicki A
    Pharmacol Rep; 2006; 58 Suppl():126-31. PubMed ID: 17332682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock.
    Wiel E; Pu Q; Leclerc J; Corseaux D; Bordet R; Lund N; Jude B; Vallet B
    Intensive Care Med; 2004 Aug; 30(8):1652-9. PubMed ID: 15024568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.